Paediatric‐onset immune‐mediated inflammatory disease is associated with an increased mortality risk—A nationwide study

Ähnliche Einträge

• Editorial: Mortality in immune‐mediated inflammatory diseases during early adulthood—Authors' reply
  von: Mikkel Malham, et al.
  Veröffentlicht: (2024)
• Treatment of inflammatory bowel disease with steroid‐sparing medications is age‐dependent – Results from a Danish nationwide cohort study, 2000–2018
  von: Rie Louise Møller Nordestgaard, et al.
  Veröffentlicht: (2024)
• Editorial: Mortality in immune‐mediated inflammatory diseases during early adulthood
  von: Paul Henderson
  Veröffentlicht: (2024)
• Allostatic load increases the incidence and risk of adverse prognosis in inflammatory bowel disease
  von: Jianhui Zhao, et al.
  Veröffentlicht: (2024)
• Oral vancomycin is associated with improved inflammatory bowel disease clinical outcomes in primary sclerosing cholangitis‐associated inflammatory bowel disease (PSC‐IBD): A matched analysis from the Paediatric PSC Consortium
  von: Amanda Ricciuto, et al.
  Veröffentlicht: (2024)